Alexander Tendler

Title: Alexander Tendler: Innovator in Tumor Suppressor Protein Therapy

Introduction

Alexander Tendler is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of medical research, particularly in the area of cancer therapy. His innovative work focuses on utilizing tumor suppressor proteins to develop effective treatment methods.

Latest Patents

Tendler holds a patent for "Native cell derived vesicles containing tumor suppressor proteins for therapy." This patent discloses a method of obtaining cell-derived vesicles that comprise an active wild-type p53 protein. The method involves isolating these vesicles from a biological sample containing cells and treating them with a DNA damaging agent. Additionally, it outlines methods for treating diseases associated with a mutant or nonfunctional p53 protein and inducing apoptosis in target cells.

Career Highlights

Tendler is associated with Exoprother Medical Ltd., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various cancers by targeting the mechanisms of tumor suppression.

Collaborations

Tendler collaborates with Lana Volokh, contributing to the innovative research at Exoprother Medical Ltd. Their combined efforts aim to enhance the understanding and application of tumor suppressor proteins in therapeutic settings.

Conclusion

Alexander Tendler's contributions to the field of cancer therapy through his innovative patent highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments targeting tumor suppressor proteins.